Missing blood pressure pills regularly may wipe out most of their protection, new analysis finds.

by Adrienne ErinSeptember 1, 2026

Around half of people prescribed blood pressure medication don’t take it exactly as directed — a skipped dose here, a forgotten refill there. New research presented at the European Society of Cardiology Congress suggests that inconsistency comes at a real cost: patients who take their medication less reliably get little to no measurable protection against heart attack and stroke, even though the same drugs work well for people who take them consistently. 

Key Takeaways

• Among more than 91,000 patients across 9 randomized trials, those who took their blood pressure medication at least 80% of the time lowered their systolic blood pressure by 5.2 mmHg more than a placebo group, compared to just 3.0 mmHg among those with lower adherence.
• People with higher adherence had an 11% lower risk of major cardiovascular events (stroke, heart attack, or heart failure requiring hospitalization or causing death); people with lower adherence saw no significant reduction in this risk at all.
• Medication adherence tended to decline over time — dropping from 88% of patients taking their medication reliably in year one to 79% by year five.
• This research was presented at a medical conference and hasn’t yet been published in a peer-reviewed journal, which is worth factoring into how much weight to give it for now.

Why This Analysis Is Different From Past Research

Doctors have long suspected that skipping doses reduces how well blood pressure medication works, but according to lead researcher Qianqian Yang, a doctoral researcher at the University of Oxford, most of that evidence previously came from observational studies — the kind that can show a pattern without ruling out other explanations, since people who take medication reliably may also differ from those who don’t in other health-relevant habits. This new analysis instead pooled individual patient data from nine actual randomized controlled trials, comparing outcomes specifically based on how consistently people took their assigned treatment. That’s a methodologically stronger approach, since randomization in the original trials helps rule out some of the confounding that limits observational research.